Encounter Resources EBITDA margin
What is the EBITDA margin of Encounter Resources?
The EBITDA margin of Encounter Resources Limited is -332.24%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Materials sector on ASX compared to Encounter Resources
What does Encounter Resources do?
Encounter Resources Limited engages in the exploration and development of mineral deposits in Australia. It explores for zinc, copper, gold, and cobalt deposits. The company holds interests in the Lamil and Yeneena projects located in the Paterson Province, Western Australia. It also holds interests in the Aileron project situated in the West Arunta, Western Australia; and the Elliott copper project located in the Northern Territory. The company was incorporated in 2004 and is based in Subiaco, Australia.
Companies with ebitda margin similar to Encounter Resources
- Forbidden Spirits Distilling has EBITDA margin of -336.58%
- European Metals has EBITDA margin of -334.90%
- Carmat SA has EBITDA margin of -333.29%
- La Jolla Pharmaceutical Co has EBITDA margin of -333.27%
- Mabpharm has EBITDA margin of -332.56%
- Elsight has EBITDA margin of -332.42%
- Encounter Resources has EBITDA margin of -332.24%
- Microba Life Sciences Ltd has EBITDA margin of -331.80%
- Global Blood Therapeutics has EBITDA margin of -330.50%
- Sienna Cancer Diagnostics has EBITDA margin of -330.16%
- Nova Royalty has EBITDA margin of -330.11%
- Vermillion has EBITDA margin of -329.33%
- Clearside Biomedical Inc has EBITDA margin of -329.31%